Indapta Therapeutics lands $22.5 million for cancer-fighting clinical trials
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
BioSpace1mon
Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
Pontifax Venture Capital, Dawn Biopharma, a platform controlled by KKR, HealthCap, Gilde Healthcare and Ysios Capital. “We are thrilled with a financing round of this magnitude and the support shown ...